Inhaled Nitric Oxide Therapy for Hypoxic Respiratory Failure in Neonates

周蓓华,张旭东,陈超,邵肖梅,黄国英,樊绍曾,孙波

DOI: https://doi.org/10.3760/cma.j.issn.1007-9408.2001.04.009

2001-01-01

Abstract:Objective To evaluate the effects of inhaled nitric oxide (iNO) in hypoxic respiratory failure in neonates. Methods Tweenty eight full term and preterm newborns requiring mechanical ventilation for hypoxic respiratory failure, with oxygenation index (OI) 25, were received iNO at a concentration of 3~15 ppm. Results Before iNO, mean FiO 2 was 0.80±0.15, SpO 2 was (0.74±0.13) and OI was 26±16. At 3 and 24 hours after iNO, FiO 2 decreased to 0.72±0.15 and 0.52±0.11 (both P 0.001), SpO 2 increased to 0.91±0.05 and 0.93±0.04 ( P 0.001), and mean OI decreased to 17±9 ( P 0.05) and 12±5 ( P 0.01), respectively. Pumonary arterial pressure was decreased from (55±10) mmHg before iNO to (39±8) mm Hg 24 h after iNO ( P 0.001). No adverse effect of iNO was detected in respect with methemoglobin level and nitrogen dioxide formation.Conclusion Inhaled NO effectively alleviated hypoxic respiratory failure in the term and preterm neonates mainly through selective pulmonary vasodilation, without causing methemoglobinemia and other potential complications.